Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Neumora Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/27/2023 |
4
| Burow Kristina (10% Owner) has filed a Form 4 on Neumora Therapeutics, Inc.
Txns:
| Bought 34,000 shares
@ $11.73, valued at
$398.8k
Bought 24,504 shares
@ $12.31, valued at
$301.6k
|
|
09/27/2023 |
4
| ARCH Venture Partners XII, LLC (10% Owner) has filed a Form 4 on Neumora Therapeutics, Inc.
Txns:
| Bought 34,000 shares
@ $11.73, valued at
$398.8k
Bought 24,504 shares
@ $12.31, valued at
$301.6k
|
|
09/27/2023 |
SC 13D
| AMGEN INC reports a 23.2% stake in Neumora Therapeutics, Inc. |
08/25/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
01/03/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
|
|